Abstract
Background Schizophrenic disorders represent one of the most common public health issues in psychiatry. An estimated 4 million people in Europe suffer from schizophrenia. The European Burden of Disease Report quotes a point prevalence of 0.25-0.56% for schizophrenia. This disorder has been demonstrated to have important social and economic consequences, so it is necessary to assess its economic burden. The aim of this study was to analyze the costs related to …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
